ALCL and Breast Implants

As a plastic surgeon, it is important to stay informed about any potential risks associated with breast implants. One of these risks is the development of anaplastic large cell lymphoma (ALCL). 

ALCL is a rare type of non-Hodgkin's lymphoma that can develop around breast implants. The condition is not breast cancer, but rather a cancer of the immune system. It is estimated that the risk of developing ALCL associated with breast implants is between 1 in 3,000 to 1 in 30,000 women with implants. 

Symptoms of ALCL can include swelling, pain, and lumps around the breast implant. It is important for patients to be aware of these symptoms and to seek medical attention if they experience them. 

While the risk of developing ALCL associated with breast implants is low, it is still important for plastic surgeons to discuss this risk with their patients and to monitor them for any signs of the condition. Patients should also be aware of the potential risks associated with breast implants and should make an informed decision about whether or not to undergo breast augmentation or reconstruction. 

As plastic surgeons, it is our responsibility to provide our patients with the most up-to-date information about the risks and benefits of any procedure. By staying informed about the potential risks associated with breast implants, we can ensure that our patients are making informed decisions about their health and well-being. 

Dr Namal Munasinghe is a fully accredited Plastic Surgeon, based in Berwick and Mulgrave